We postulate that the increased total tumour burden, without new tumour types, in the compound Men1+/−: Trp53+/− cohort underlies the slightly shorter median survival of the compound heterozygous animals, compared to heterozygous loss of either of these tumour suppressor genes alone. The gene discussed is MEN1; the disease is neoplasm.